- TheStreet.com•7 days ago
Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.
- Barrons.com•last month
Review | Dates to Watch For | Follow-Up | U.S. Economic Calendar | Consensus Estimates | Coming Earnings | Coming U.S. Auctions Cheese prices have crumbled this year faster than a good Gorgonzola. Growing ...
After hours: 9.980.00 (0.02%) as of 4:41 PM EDT
|Bid||8.14 x 100|
|52wk Range||8.27 - 23.35|
|Day's Range||9.72 - 10.06|
|Avg Vol (3m)||356,844|
As of 4:00 PM EDT. Market closed.